FIELD: medicine.
SUBSTANCE: emergency coronary angiography is performed: for patients diagnosed with acute coronary syndrome without ST segment elevation, if at least one of the "high risk factors" is detected; for patients with acute coronary syndrome with ST segment elevation, who did not undergo thrombolytic therapy at the prehospital stage; for patients with acute coronary syndrome with ST segment elevation, who underwent thrombolytic therapy, but it was not effective. Coronary angiography is urgently performed for 3-6 h: for patients with acute coronary syndrome without ST segment elevation, in the absence of "high-risk factors", in the absence of troponin I level elevation, with a GRACE score>140; for patients with acute coronary syndrome with ST segment elevation, if the effect of the thrombolytic therapy on prehospital stage is revealed. Coronarography is performed in a delayed manner for 24 hours for patients diagnosed with acute coronary syndrome without ST segment elevation, in the absence of "high risk factors", in the absence of troponin I level increase, with a GRACE score>108<140, if one of the factors exists; for patients with acute coronary syndrome without ST segment elevation, in the absence of "high-risk factors", in the absence of troponin I increase, with a GRACE score>108<140, in the absence of one of the factors. Coronarography is not performed: for patients with acute coronary syndrome without ST segment elevation, in the absence of "high risk factors", in the absence of troponin I increase, with a GRACE score of <108.
EFFECT: method allows to reduce hospital lethality and risk of haemorrhagic complications, and allows to make a decision in a short time about the timeliness and urgency of coronary angiography and intermittent coronary intervention according to its results.
1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING THE "NO-REFLOW" PHENOMENON DURING CORONARY ARTERY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST ELEVATION DUE TO MASSIVE THROMBOSIS | 2021 |
|
RU2786150C1 |
METHOD OF TREATMENT OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH MASSIVE THROMBOSIS OF THE INFARCT-RELATED CORONARY ARTERY | 2017 |
|
RU2649572C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF MASSIVE CORONARY THROMBOSIS OF AN INFARCTION-RESPONSIBLE CORONARY ARTERY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2022 |
|
RU2792252C1 |
OTAMIXABAN FOR TREATING NON-ST ELEVATION MYOCARDIAL INFARCTION IN SENIOR PATIENTS AND PATIENTS SUFFERING DISTURBED RENAL FUNCTION | 2010 |
|
RU2542455C2 |
METHOD FOR REVASCULARISATION OF MULTIPLE CORONARY BED LESION ACCOMPANYING ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2013 |
|
RU2544096C1 |
METHOD FOR PREDICTION OF PROGRESSION OF CARDIOVASCULAR COMPLICATIONS OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | 2014 |
|
RU2567031C1 |
METHOD OF ACUTE MYOCARDIAL INFARCTION TREATMENT | 2008 |
|
RU2365380C1 |
METHOD OF TREATMENT OF ACUTE MYOCARDIAL INFARCTION WITH STAGING OF ST SEGMENT COMPLICATED BY CARDIOGENIC SHOCK | 2017 |
|
RU2649760C1 |
METHOD OF DETERMINING POSTOPERATIVE MANAGEMENT OF PATIENTS WITH CORONARY HEART DISEASE BASED ON THE SELECTED CLASSES OF ANGIOGRAPHIC RESULTS OF PERCUTANEOUS CORONARY INTERVENTION | 2022 |
|
RU2802854C1 |
METHOD FOR SELECTION OF OPTIMAL DOSE OF UNFRACTIONATED HEPARIN IN SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT SEGMENT ST RISE | 2002 |
|
RU2223766C1 |
Authors
Dates
2018-01-22—Published
2015-08-04—Filed